Citations to this article

Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.
S Nonoyama, … , M Howard, H D Ochs
S Nonoyama, … , M Howard, H D Ochs
Published September 1, 1993
Citation Information: J Clin Invest. 1993;92(3):1282-1287. https://doi.org/10.1172/JCI116701.
View: Text | PDF
Research Article

Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.

Abstract

Most patients with common variable immunodeficiency (CVI) have normal numbers of circulating B cells but low concentrations of serum Ig. To determine if the hypogammaglobulinemia is caused by an intrinsic B cell defect, we studied B cell function of 22 CVI patients. Cultured B cells from all CVI patients underwent normal proliferation and synthesized normal quantities of IgE in the presence of anti-CD40 and IL-4. If cultured with anti-CD40 and IL-10, four patterns of Ig isotype synthesis were observed. Six CVI patients produced normal amounts of IgM, IgG, and IgA. Four patients produced normal quantities of IgM and IgG. Of the remaining 12 patients who failed to synthesize IgG and IgA, 8 produced normal and 4 synthesized decreased amounts of IgM. Analysis of the IgG subclasses produced by 10 patients with IgG-secreting B cells revealed that IgG4 was the most affected subclass, followed by IgG2; synthesis of IgG3 and IgG1 remained normal. Similarly, in the six IgA producing patients, IgA2 was more often affected than IgA1. The hierarchy of Ig isotype and subclass synthesis corresponds to Ig heavy chain constant region gene location on chromosome 14. Thus, circulating B cells of CVI patients are committed to synthesize one or more Ig isotypes or subclasses, and under proper conditions can proliferate, mature into Ig-secreting cells, and undergo class switch to IgE.

Authors

S Nonoyama, M Farrington, H Ishida, M Howard, H D Ochs

×

Total citations by year

Year: 2013 2011 2010 2009 2006 2005 2004 2003 2002 2001 2000 1998 1997 1996 1995 1994 Total
Citations: 1 4 1 2 1 5 3 4 2 3 5 3 3 2 7 4 50
Citation information

Citations to this article (50)

Title and authors Publication Year
Evaluation of class switch recombination in B lymphocytes of patients with common variable immunodeficiency
AS Farrokhi, A Aghamohammadi, S Pourhamdi, P Mohammadinejad, H Abolhassani, SM Moazzeni 		Journal of Immunological Methods 2013
Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature
NE Karaca, A Durandy, N Gulez, G Aksu, N Kutukculer 		European Journal of Pediatrics 2011
Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination
Z Chovancova, M Vlkova, J Litzman, J Lokaj, V Thon 		Vaccine 2011
Cytokines
L Cassetta, G Poli, M Alfano 		Cytokines 2011
Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies
J Bayry, EM Fournier, MS Maddur, J Vani, B Wootla, S Sibéril, JD Dimitrov, S Lacroix-Desmazes, M Berdah, Y Crabol, E Oksenhendler, Y Lévy, L Mouthon, C Sautès-Fridman, O Hermine, SV Kaveri 		Journal of Autoimmunity 2011
Topley & Wilson's Microbiology and Microbial Infections
PM Pitha, MS Künzi 		Topley & Wilson's Microbiology and Microbial Infections 2010
Role of B cells in common variable immune deficiency
S Ahn, C Cunningham-Rundles 		Expert Review of Clinical Immunology 2009
Common Variable Immunodeficiency
FA Bonilla, RS Geha 		Pediatric Research 2009
TLR9 Activation Is Defective in Common Variable Immune Deficiency
C Cunningham-Rundles, L Radigan, AK Knight, L Zhang, L Bauer, A Nakazawa 		Journal of immunology (Baltimore, Md. : 1950) 2006
Deficient IL-12 and dendritic cell function in common variable immune deficiency
C Cunningham-Rundles, L Radigan 		Clinical Immunology 2005
Cough and weight loss in a patient with cystic fibrosis
B Khalili, A Montanaro 		Annals of Allergy Asthma & Immunology 2005
Common Variable Immunodeficiency: Test Indications and Interpretations
CR Weiler, JL Bankers-Fulbright 		Mayo Clinic Proceedings 2005
Mucosal Immunology
WR Brown 		Mucosal Immunology 2005
Immunodeficiency and Mucosal Immunity
Cunningham-Rundles C 		Mucosal Immunology 2005
The Molecular Pathology of Primary Immunodeficiencies
MS Lim, KS Elenitoba-Johnson 		The Journal of Molecular Diagnostics 2004
Common Variable Immunodeficiency and Breast Cancer
AC Mehta, K Faber-Langendoen, DB Duggan 		Cancer Investigation 2004
Clinical and laboratory aspects of common variable immunodeficiency
CM Kokron, PR Errante, MT Barros, GV Baracho, MM Camargo, J Kalil, LV Rizzo 		Anais da Academia Brasileira de Ciências 2004
Hyper-IgM syndrome type 4 with a B-lymphocyte intrinsic selective deficiency in immunoglobulin class switch recombination
Kohsuke Imai, Nadia Catalan, Alessandro Plebani, László Maródi, Özden Sanal, Satoru Kumaki, Vasantha Nagendran, Philip Wood, Catherine Glastre, Françoise Sarrot-Reynauld, Olivier Hermine, Monique Forveille, Patrick Revy, Alain Fischer, and Anne Durandy 		Journal of Clinical Investigation 2003
B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro
DM Stewart, MJ McAvoy, DM Hilbert, DL Nelson 		Clinical Immunology 2003
Le déficit immunitaire commun variable de l’adulte : étude clinique, biologique et immunologique chez 17 patients
C Bloch-Michel, JF Viallard, P Blanco, F Liferman, D Neau, JF Moreau, L Baillet, G Etienne, M Longy-Boursier, JL Pellegrin 		La Revue de Médecine Interne 2003
Therapeutic Strategies in Common Variable Immunodeficiency:
WA Sewell, MS Buckland, SR Jolles 		Drugs 2003
Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID)
C Groth, R Drager, K Warnatz, G Wolff-Vorbeck, S Schmidt, H Eibel, M Schlesier, HH Peter 		Clinical & Experimental Immunology 2002
Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients
JA Cabanillas, R Cambronero, A Pacheco-Castro, MC García-Rodríguez, JM Martín-Fernández, G Fontán, JR Regueiro 		Clinical & Experimental Immunology 2002
Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID)
N Pozzi, L Gaetaniello, B Martire, DD Mattia, B Balestrieri, E Cosentini, SF Schlossman, JS Duke-Cohan, C Pignata 		Clinical & Experimental Immunology 2001
COMMON VARIABLE IMMUNODEFICIENCY
AD Webster 		Immunology and Allergy Clinics of North America 2001
CD40:CD40L Interactions in X-linked and Non-X-linked Hyper-IgM Syndromes
A Bhushan, LR Covey 		Immunologic Research 2001
Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
Aukrust, Muller, Ueland, Svardal, Berge, Froland 		European Journal of Clinical Investigation 2000
Effect of TEI-9874, an inhibitor of immunoglobulin E production, on allergen-induced asthmatic model in rats
T Nonaka, H Mitsuhashi, K Takahashi, H Sugiyama, T Kishimoto 		European Journal of Pharmacology 2000
Congenital C2 (Type I) Deficiency Associated with Common Variable Immunodeficiency
ME Soto, F Cordera, PA Reyes 		Annals of internal medicine 2000
A Transcriptional Defect Underlies B Lymphocyte Dysfunction in a Patient Diagnosed with Non-X-Linked Hyper-IgM Syndrome
A Bhushan, B Barnhart, S Shone, C Song, LR Covey 		Journal of immunology (Baltimore, Md. : 1950) 2000
Common Variable Immunodeficiency
W Strober, K Chua 		Clinical Reviews in Allergy & Immunology 2000
Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin
X Meng, D Sawamura, K Tamai, K Hanada, H Ishida, I Hashimoto 		Journal of Clinical Investigation 1998
Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency
S Nonoyama, A Etzioni, H Toru, DP Ruggerie, D Lewis, S Pollack, A Aruffo, JI Yata, HD Ochs 		European Journal of Immunology 1998
IL-10 Production in Common Variable Immunodeficiency
Z Zhou, R Huang, M Danon, L Mayer, C Cunningham-Rundles 		Clinical Immunology and Immunopathology 1998
A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)
JA Rump, A Jahreis, M Schlesier, S Stecher, HH Peter 		Clinical & Experimental Immunology 1997
Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients
V Thon, HM Wolf, M Sasgary, J Litzman, A Samstag, I Hauber, J Lokaj, MM Eibl 		Clinical & Experimental Immunology 1997
Normal Immunologic Response to a Neoantigen, Bacteriophage ΦX-174, in Baboons With Long-Term Lymphohematopoietic Reconstitution From Highly Purified CD34+ Lin− Allogeneic Marrow Cells
RG Andrews, A Winkler, J Potter, E Bryant, GH Knitter, ID Bernstein, HD Ochs 		Blood 1997
Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency
MB Fischer, HM Wolf, I Hauber, H Eggenbauer, V Thon, M Sasgary, MM Eibl 		European Journal of Immunology 1996
CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation
D Brugnoni, P Airò, M Lebovitz, F Malacarne, AG Ugazio, LD Notarangelo, A Plebani, R Cattaneo 		Pediatric Allergy and Immunology 1996
Common variable immunodeficiency: Clinical aspects and recent progress in identifying the immunological defect(s)
MM Eibl, HM Wolf 		Folia Microbiologica 1995
B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis
A Saxon, B Keld, D Diaz-Sanchez, BC Guo, N Sidell 		Clinical & Experimental Immunology 1995
Immunologic Effects of Low-Dose Polyethylene Glycol-Conjugated Recombinant Human Interleukin-2 in Common Variable Immunodeficiency
C Cunningham-Rundles, K Kazbay, Z Zhou, L Mayer 		Journal of Interferon & Cytokine Research 1995
The Primary Immunodeficiencies
FS Rosen, MD Cooper, RJ Wedgwood 		New England Journal of Medicine 1995
Suppression of human immunoglobulin E antibody production by a new naphthalene derivative
Y Uejima, K Takahashi, K Komoriya, S Kurozumi, HD Ochs 		Immunopharmacology 1995
Interleukin-10
JE de Vries, R de Waal Malefyt 		1995
B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis.
Saxon A, Keld B, Diaz-Sanchez D, Guo BC, Sidell N 		Clinical & Experimental Immunology 1995
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA
F Brière, JM Bridon, D Chevet, G Souillet, F Bienvenu, C Guret, H Martinez-Valdez, J Banchereau 		Journal of Clinical Investigation 1994
Hyper IgM syndrome associated with defective CD40-mediated B cell activation
ME Conley, M Larché, VR Bonagura, AR 3rd, RH Buckley, SM Fu, E Coustan-Smith, HG Herrod, D Campana 		Journal of Clinical Investigation 1994
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency
M Farrington, LS Grosmaire, S Nonoyama, SH Fischer, D Hollenbaugh, JA Ledbetter, RJ Noelle, A Aruffo, HD Ochs 		Proceedings of the National Academy of Sciences 1994
Breakthroughs in the Understanding and Therapy of Primary Immunodeficiency
RH Buckley 		Pediatric Clinics of North America 1994

Advertisement